Expression of the nogo-A system in cortical lesions of pediatric patients with tuberous sclerosis complex and focal cortical dysplasia type IIb

Journal of Neuropathology and Experimental Neurology

Volumn 71, Issue 7, 2012, Pages 665-677

  Yu, Si Xun ^a   Li, Song ^a   Shu, Hai Feng ^a   Zhang, Chun Qing ^a   Liu, Shi Yong ^a   Yang, Hui ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN NOGO A; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ARTICLE; AUTOPSY; BRAIN CORTEX LESION; BRAIN DEVELOPMENT; BRAIN MALFORMATION; CHILD; CLINICAL ARTICLE; CORTICAL DYSPLASIA; DISEASE ASSOCIATION; EPILEPSY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; TUBEROUS SCLEROSIS; UPREGULATION;

ANALYSIS OF VARIANCE; BRAIN DISEASES; CEREBRAL CORTEX; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION REGULATION; GPI-LINKED PROTEINS; HUMANS; INFANT; MALE; MALFORMATIONS OF CORTICAL DEVELOPMENT; MYELIN PROTEINS; NERVE TISSUE PROTEINS; RECEPTORS, CELL SURFACE; RECEPTORS, TUMOR NECROSIS FACTOR; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; TUBEROUS SCLEROSIS;

EID: 84862878866     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0b013e31825d6585     Document Type: Article

References (44)

1. Blumcke I, Vinters HV, Armstrong D, et al. Malformations of cortical development and epilepsies: Neuropathological findings with emphasis on focal cortical dysplasia. Epileptic Disord 2009;11:181-93
2. Barkovich AJ, Kuzniecky RI, Jackson GD, et al. A developmental and genetic classification for malformations of cortical development. Neurology 2005;65:1873-87 (Pubitemid 43970104)
3. Wang KC, Koprivica V, Kim JA, et al. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature 2002;417:941-44 (Pubitemid 34716869)
4. Huber AB, Weinmann O, Brosamle C, et al. Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesions. J Neurosci 2002;22:3553-67 (Pubitemid 37465761)
5. Park JB, Yiu G, Kaneko S, et al. A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors. Neuron 2005;45:345-51 (Pubitemid 40188202)
6. Wang KC, Kim JA, Sivasankaran R, et al. P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp. Nature 2002; 420:74-78 (Pubitemid 35291442)
7. Petrinovic MM, Duncan CS, Bourikas D, et al. Neuronal Nogo-A regulates neurite fasciculation, branching and extension in the developing nervous system. Development 2010;137:2539-50
8. Wang J, Chan CK, Taylor JS, et al. The growth-inhibitory protein Nogo is involved in midline routing of axons in the mouse optic chiasm. J Neurosci Res 2008;86:2581-90
9. Mathis C, Schroter A, Thallmair M, et al. Nogo-A regulates neural precursor migration in the embryonic mouse cortex. Cereb Cortex 2010;20: 2380-90
10. Lee JK, Kim JE, Sivula M, et al. Nogo receptor antagonism promotes stroke recovery by enhancing axonal plasticity. J Neurosci 2004;24: 6209-17 (Pubitemid 38891112)
11. Lee H, Raiker SJ, Venkatesh K, et al. Synaptic function for the Nogo-66 receptor NgR1: Regulation of dendritic spine morphology and activitydependent synaptic strength. J Neurosci 2008;28:2753-65 (Pubitemid 351398865)
12. Fontoura P,Ho PP, DeVoss J, et al. Immunity to the extracellular domain of Nogo-A modulates experimental autoimmune encephalomyelitis. J Immunol 2004;173:6981-92 (Pubitemid 39541087)
13. Bandtlow CE, Dlaska M, Pirker S, et al. Increased expression of Nogo-A in hippocampal neurons of patients with temporal lobe epilepsy. Eur J Neurosci 2004;20:195-206 (Pubitemid 38932140)
14. Dupuis L, Gonzalez de Aguilar JL, di Scala F, et al. Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis. Neurobiol Dis 2002;10:358-65 (Pubitemid 35217587)
15. Gil V, Nicolas O, Mingorance A, et al. Nogo-A expression in the human hippocampus in normal aging and in Alzheimer disease. J Neuropathol Exp Neurol 2006;65:433-44 (Pubitemid 44297265)
16. Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N Engl J Med 2006;355:1345-56
17. Pang T, Atefy R, Sheen V. Malformations of cortical development. Neurologist 2008;14:181-91 (Pubitemid 351671258)
18. Blumcke I, Thom M, Aronica E, et al. The clinicopathologic spectrum of focal cortical dysplasias: A consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia 2011;52:158-74
19. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(jDelta Delta C(T)) method. Methods 2001;25:402-8 (Pubitemid 34164012)
20. Toering ST, Boer K, de Groot M, et al. Expression patterns of synaptic vesicle protein 2A in focal cortical dysplasia and TSC-cortical tubers. Epilepsia 2009;50:1409-18
21. Schick V, Majores M, Engels G, et al. Differential PI3K-pathway activation in cortical tubers and focal cortical dysplasias with balloon cells. Brain Pathol 2007;17:165-73 (Pubitemid 46466136)
22. DiMario FJ Jr. Brain abnormalities in tuberous sclerosis complex. J Child Neurol 2004;19:650-57 (Pubitemid 39530073)
23. Buss A, Sellhaus B, Wolmsley A, et al. Expression pattern of NOGO-A protein in the human nervous system. Acta Neuropathol 2005;110:113-19 (Pubitemid 41245199)
24. Aronica E, Ozbas-Gerceker F, Redeker S, et al. Expression and cellular distribution of high-and low-affinity neurotrophin receptors in malformations of cortical development. Acta Neuropathol 2004;108:422-34 (Pubitemid 39462354)
25. Satoh J, Tabunoki H, Yamamura T, et al. TROY and LINGO-1 expression in astrocytes and macrophages/microglia in multiple sclerosis lesions. Neuropathol Appl Neurobiol 2007;33:99-107 (Pubitemid 46090314)
26. Wang X, Chun SJ, Treloar H, et al. Localization of Nogo-A and Nogo-66 receptor proteins at sites of axon-myelin and synaptic contact. J Neurosci 2002;22:5505-15 (Pubitemid 35386472)
27. Schramm M, Falkai P, Tepest R, et al. Stability of RNA transcripts in post-mortem psychiatric brains. J Neural Transm 1999;106:329-35 (Pubitemid 29196936)
28. Satoh J, Onoue H, Arima K, Yamamura T. Nogo-A and Nogo receptor expression in demyelinating lesions of multiple sclerosis. J Neuropathol Exp Neurol 2005e;64:129-38 (Pubitemid 40349311)
29. Takeda Y, Kamida T, Fujiki M, Kobayashi H. Hippocampal Nogo-A and neo-Timm's staining in amygdala kindling rats. Neurol Res 2007e;29: 199-203 (Pubitemid 46685272)
30. Mukaino M, Nakamura M, Yamada O, et al. AntiYIL-6-receptor antibody promotes repair of spinal cord injury by inducing microglia-dominant inflammation. Exp Neurol 2010;224:403-14
31. Shu HF, Zhang CQ, Yin Q, et al. Expression of the interleukin 6 system in cortical lesions from patients with tuberous sclerosis complex and focal cortical dysplasia type IIb. J Neuropathol Exp Neurol 2010;69:838-49
32. Schwab ME. Functions of Nogo proteins and their receptors in the nervous system. Nat Rev Neurosci 2010;11:799-811
33. Aloy EM, Weinmann O, Pot C, et al. Synaptic destabilization by neuronal Nogo-A. Brain cell biology 2006;35:137-56
34. Liewald JF, Brauner M, Stephens GJ, et al. Optogenetic analysis of synaptic function. Nature methods 2008;5:895-902
35. Wang Y, Greenwood JS, Calcagnotto ME, et al. Neocortical hyperexcitability in a human case of tuberous sclerosis complex and mice lacking neuronal expression of TSC1. Ann Neurol 2007;61:139-52 (Pubitemid 46363841)
36. Cepeda C, Andre VM, Levine MS, et al. Epileptogenesis in pediatric cortical dysplasia: The dysmature cerebral developmental hypothesis. Epilepsy Behav 2006;9:219-35 (Pubitemid 44307962)
37. Wong M. Mechanisms of epileptogenesis in tuberous sclerosis complex and related malformations of cortical development with abnormal glioneuronal proliferation. Epilepsia 2008;49:8-21
38. Su Z, Cao L, Zhu Y, et al. Nogo enhances the adhesion of olfactory ensheathing cells and inhibits their migration. J Cell Sci 2007;120:1877-87 (Pubitemid 46979779)
39. Leong SY, Faux CH, Turbic A, et al. The Rho kinase pathway regulates mouse adult neural precursor cell migration. Stem Cells 2011;29:332-43
40. Leong SY, Turnley AM. Regulation of adult neural precursor cell migration. Neurochem Int 2011;59:382-93
41. Shao Z, Browning JL, Lee X, et al. TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration. Neuron 2005;45:353-59 (Pubitemid 40188203)
42. McDonald CL, Bandtlow C, Reindl M. Targeting the Nogo receptor complex in diseases of the central nervous system. Curr Med Chem 2011;18: 234-44
43. Hisaoka T, Morikawa Y, Kitamura T, et al. Expression of a member of tumor necrosis factor receptor superfamily, TROY, in the developing mouse brain. Brain Res Dev Brain Res 2003;143:105-9 (Pubitemid 36588687)
44. Paulino VM, Yang Z, Kloss J, et al. TROY (TNFRSF19) is overexpressed in advanced glial tumors and promotes glioblastoma cell invasion via Pyk2-Rac1 signaling. Mol Cancer Res 2010;8:1558-67